Gujarat Magazine

Creative Biolabs: “Messenger” to Boost Nucleic Acid Drug Discovery

 Breaking News
  • No posts were found

Creative Biolabs: “Messenger” to Boost Nucleic Acid Drug Discovery

April 23
17:28 2024
Creative Biolabs continues to be at the forefront of mRNA research and nucleic acid therapy development, offering unparalleled solutions to scientists and pharmaceutical companies worldwide.

New York, USA – April 23, 2024 – SARS-CoV-2 seems to have ceased its fire at the moment, with scattered reports coming out occasionally, yet global researchers’ efforts on mRNA therapeutics, like mRNA vaccines or other nucleic acid drugs, remain persistent and on the rise. With a steadfast commitment to innovation and excellence, Creative Biolabs empowers researchers to navigate the complexities of mRNA-based technologies and drive forward groundbreaking research initiatives.

“At Creative Biolabs, we specialize in custom mRNA synthesis, providing researchers with tailored solutions to fit in with their attempts to find out mRNA molecules of versatility. Our state-of-the-art synthesis platform enables precise control over mRNA sequence, length, and modifications, ensuring the production of high-quality mRNA molecules for a wide range of applications.” According to a scientist at Creative Biolabs.

mRNA synthesis can typically be categorized into chemical synthesis and in vitro transcription, and chemical approaches are prioritized when the projected mRNA fragment is small in size because they are more cost-effective in both time and money. The chemically synthesized RNA can be used for vaccine development, genome editing, and mRNA amplification-based diagnostics. Scientists at Creative Biolabs use the solid-phase synthesis method to produce volumes of modified RNA to be further improved in purity.

“Advances in intracellular delivery methods make it possible for the clinical translation of mRNA therapeutics. Creative Biolabs can assist with the exploration of efficient delivery systems that can enhance mRNA stability, improve tissue permeability, and exhibit low cytotoxicity and immunogenicity. Our lipid nanoparticle development is one of a kind.” Said the scientist. “We mainly use ultrasonic, supercritical fluid technology, high pressure homogenization, ultrafiltration, and surfactant flocculation to produce potent mRNA delivery agents.”

All in all, mRNA serves as a versatile research tool with diverse applications across miscellaneous fields. Creative Biolabs’ comprehensive mRNA-based solutions, including mRNA expression vectors, reporter mRNA constructs, and mRNA-based vaccines, empower researchers to explore gene expression, protein production, and immunotherapy with unparalleled flexibility and reliability.

For more information about Creative Biolabs and the mRNA solutions, please visit

Company Overview

Creative Biolabs is a leading provider of innovative solutions for molecular biology research and nucleic acid drug development. With a multidisciplinary team of experts and state-of-the-art facilities, Creative Biolabs supports all stages of nucleic acid therapy development. From mRNA synthesis and nanoparticle delivery to gene editing and beyond, the scientists are committed to delivering transformative solutions that address the evolving needs of the biopharmaceutical industry.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States